These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18564554)

  • 21. Managed care's influence felt on brand-name drugs.
    Manag Care; 1999 Nov; 8(11):70. PubMed ID: 10977327
    [No Abstract]   [Full Text] [Related]  

  • 22. Etanercept provides a more physiological approach in the treatment of psoriasis.
    Altomare G; Ayala F; Berardesca E; Chimenti S; Giannetti A; Girolomoni G; Lotti T; Martini P; Peserico A; Guerra AP; Vena GA
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S1-14. PubMed ID: 18837727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managed care's methods for determining coverage of plastic surgery procedures: the example of reduction mammaplasty.
    Krieger LM; Lesavoy MA
    Plast Reconstr Surg; 2001 Apr; 107(5):1234-40. PubMed ID: 11373569
    [No Abstract]   [Full Text] [Related]  

  • 24. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.
    Wozel G
    Clin Dermatol; 2008; 26(5):448-59. PubMed ID: 18755363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experience with etanercept in the treatment of psoriasis].
    Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
    Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State Medicaid coverage for tobacco-dependence treatments - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(43):1199-204. PubMed ID: 19893479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managed care's customers: the typical American family.
    Manag Care Interface; 2000 Aug; 13(8):42-3. PubMed ID: 11185171
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany.
    Augustin M; Radtke M; van Engen A; Ruedig C; Lapp C; Moehling U
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):329-38. PubMed ID: 19243481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managed care's roller coaster. Recession could lead to another premium increase.
    Vesely R
    Mod Healthc; 2008 Oct; 38(42):8-9. PubMed ID: 18975417
    [No Abstract]   [Full Text] [Related]  

  • 31. [The biological treatments for moderate to severe plaque psoriasis].
    Thielen AM; Marazza G
    Rev Med Suisse; 2008 Apr; 4(155):1089-90, 1092-4. PubMed ID: 18610721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediating disputes in managed care: resolving conflicts over covered services.
    Dubler NN
    J Health Care Law Policy; 2002; 5(2):479-501. PubMed ID: 15017947
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs".
    Spandonaro F; Ayala F; Berardesca E; Chimenti S; Girolomoni G; Martini P; Peserico A; Polistena B; Guerra AP; Vena GA; Altomare G; Pinton PC
    BioDrugs; 2015 Feb; 29(1):71-2. PubMed ID: 25647521
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate quality-adjusted life-years.
    Scalone L; Cortesi PA
    BioDrugs; 2015 Feb; 29(1):69. PubMed ID: 25633571
    [No Abstract]   [Full Text] [Related]  

  • 35. Economic considerations in psoriasis management.
    Radtke MA; Augustin M
    Clin Dermatol; 2008; 26(5):424-31. PubMed ID: 18755360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National registries of systemic treatment for psoriasis and the European 'Psonet' initiative.
    Lecluse LL; Naldi L; Stern RS; Spuls PI
    Dermatology; 2009; 218(4):347-56. PubMed ID: 19077384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
    Zachariae C; Mørk NJ; Reunala T; Lorentzen H; Falk E; Karvonen SL; Johannesson A; Claréus B; Skov L; Mørk G; Walker S; Qvitzau S
    Acta Derm Venereol; 2008; 88(5):495-501. PubMed ID: 18779890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic therapies for psoriasis.
    de Felice C; Ardigo M; Berardesca E
    J Rheumatol Suppl; 2009 Aug; 83():62-4. PubMed ID: 19661545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managed care's price bargaining with hospitals.
    Wu VY
    J Health Econ; 2009 Mar; 28(2):350-60. PubMed ID: 19108922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From basic research to biological treatments: psoriasis publications over the past 15 years.
    Pavlovsky L; Mimouni FB; Hodak E; David M; Mimouni D
    Clin Exp Dermatol; 2009 Jul; 34(5):e91-3. PubMed ID: 19438559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.